cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- And RIPK3-dependent manner

Blood

Volumn 123, Issue 16, 2014, Pages 2562-2572

  Wong, W Wei Lynn ^a,b,c,d   Vince, James E ^a,b   Lalaoui, Najoua ^a,b   Lawlor, Kate E ^a,b   Chau, Diep ^a   Bankovacki, Aleksandra ^a   Anderton, Holly ^a   Metcalf, Donald ^a,b   O'Reilly, Lorraine ^a,b   Jost, Philipp J ^a,e   Murphy, James M ^a,b   Alexander, Warren S ^a,b   Strasser, Andreas ^a,b   Vaux, David L ^a,b   Silke, John ^a,b,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; EOTAXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MIXED LINEAGE KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; CYTOKINE; INHIBITOR OF APOPTOSIS PROTEIN; RIPK1 PROTEIN, MOUSE; RIPK3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL KILLING; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE TARGETING; GRANULOCYTOSIS; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; MYELOID PROGENITOR CELL; MYELOPOIESIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN HOMEOSTASIS; SECRETION (PROCESS); SPLENOMEGALY; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; GENE DELETION; GENETICS; GRANULOCYTE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CYTOKINES; GENE DELETION; GRANULOCYTES; INFLAMMATION; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOPOIESIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SPLENOMEGALY; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84899112438     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-510743     Document Type: Article

References (50)

1. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388(6639):300-304. (Pubitemid 27317977)
2. Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem. 2006;281(6): 3254-3260. (Pubitemid 43845937)
3. Bertrand MJM, Milutinovic S, Dickson KM, et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008;30(6):689-700. (Pubitemid 351818251)
4. Mahoney DJ, Cheung HH, Mrad RL, et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA. 2008;105(33):11778-11783.
5. Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell. 2008;133(4):693-703. (Pubitemid 351636305)
6. Gaither A, Porter D, Yao Y, et al. A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res. 2007;67(24):11493-11498.
7. Petersen SL, Wang L, Yalcin-Chin A, et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell. 2007;12(5):445-456. (Pubitemid 350064365)
8. Varfolomeev E, Blankenship JW, Wayson SM, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007;131(4):669-681. (Pubitemid 350087204)
9. Vince JE, Wong WW-L, Khan N, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 2007;131(4):682-693. (Pubitemid 350103599)
10. McComb S, Cheung HH, Korneluk RG, Wang S, Krishnan L, Sad S. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ. 2012;19(11):1791-1801.
11. Müller-Sienerth N, Dietz L, Holtz P, et al. SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells. PLoS ONE. 2011;6(6):e21556.
12. Bauler LD, Duckett CS, O'Riordan MXD. XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog. 2008;4(8):e1000142.
13. Bertrand MJM, Doiron K, Labbé K, Korneluk RG, Barker PA, Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity. 2009; 30(6):789-801.
14. Krieg A, Correa RG, Garrison JB, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci USA. 2009;106(34): 14524-14529.
15. Damgaard RB, Nachbur U, Yabal M, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell. 2012;46(6):746-758.
16. Kearney CJ, Sheridan C, Cullen SP, et al. Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production. J Biol Chem. 2013;288(7):4878-4890.
17. Rigaud S, Fondanèche M-C, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006; 444(7115):110-114. (Pubitemid 44684766)
18. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13(3):255-262.
19. Vandenabeele P, Melino G. The flick of a switch: which death program to choose? Cell Death Differ. 2012;19(7):1093-1095.
20. Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012; 148(1-2):213-227.
21. Wang Z, Jiang H, Chen S, Du F, Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell. 2012;148(1-2):228-243.
22. Zhang D-W, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325(5938):332-336.
23. Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling. Cell. 2011; 145(1):92-103.
24. Feoktistova M, Geserick P, Kellert B, et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell. 2011;43(3):449-463.
25. Geserick P, Hupe M, Moulin M, et al. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol. 2009; 187(7):1037-1054.
26. Tenev T, Bianchi K, Darding M, et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell. 2011;43(3):432-448.
27. Christofferson DE, Li Y, Hitomi J, et al. A novel role for RIP1 kinase in mediating TNFα production. Cell Death Dis. 2012;3(6):e320.
28. Gardam S, Turner VM, Anderton H, et al. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood. 2011;117(15):4041-4051.
29. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277. (Pubitemid 29523965)
30. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 1998;8(3):297-303. (Pubitemid 28188890)
31. Newton K, Sun X, Dixit VM. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol. 2004;24(4):1464- 1469. (Pubitemid 38167070)
32. Murphy JM, Czabotar PE, Hildebrand JM, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013;39(3):443-453.
33. Rodríguez CI, Buchholz F, Galloway J, et al. Highefficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet. 2000;25(2): 139-140. (Pubitemid 30394979)
34. Cross M, Mangelsdorf I, Wedel A, Renkawitz R. Mouse lysozyme M gene: isolation, characterization, and expression studies. Proc Natl Acad Sci USA. 1988;85(17):6232-6236.
35. He S, Wang L, Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 2009;137(6): 1100-1111.
36. Vanlangenakker N, Bertrand MJM, Bogaert P, Vandenabeele P, Vanden Berghe T. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis. 2011;2(11):e230.
37. Kaiser WJ, Upton JW, Long AB, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 2011;471(7338):368-372.
38. Oberst A, Dillon CP, Weinlich R, et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 2011; 471(7338):363-367.
39. Oost TK, Sun C, Armstrong RC, et al. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J Med Chem. 2004;47(18):4417-4426. (Pubitemid 39096830)
40. Vince JE, Wong WW-L, Gentle I, et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity. 2012;36(2): 215-227.
41. Bonnet MC, Preukschat D, Welz P-S, et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity. 2011;35(4):572-582.
42. Welz P-S, Wullaert A, Vlantis K, et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature. 2011; 477(7364):330-334.
43. Günther C, Martini E, Wittkopf N, et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature. 2011;477(7364): 335-339.
44. Kang T-B, Ben-Moshe T, Varfolomeev EE, et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol. 2004;173(5):2976-2984. (Pubitemid 39142002)
45. Huang Q-Q, Perlman H, Huang Z, et al. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood. 2010; 116(23):4968-4977.
46. Rébé C, Cathelin S, Launay S, et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood. 2007;109(4):1442-1450. (Pubitemid 46239575)
47. Marsh RA, Madden L, Kitchen BJ, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;116(7):1079-1082.
48. Vince JE, Chau D, Callus B, et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol. 2008;182(1):171-184. (Pubitemid 352008630)
49. Wicovsky A, Salzmann S, Roos C, et al. TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling. Cell Death Differ. 2009;16(11):1445-1459.
50. Ikner A, Ashkenazi A. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8. J Biol Chem. 2011;286(24):21546-21554.